Matches in Nanopublications for { ?s ?p "[Somatic mutations in AA patients with a disease duration of >6 months were associated with a 40% risk of transformation to MDS (P < .0002).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 10 of
10
with 100 items per page.
- NP914125.RAYYpjvbNASoBOJzT9Hb-J26KCPG7ZPv--NFg6qOAH5dg130_assertion description "[Somatic mutations in AA patients with a disease duration of >6 months were associated with a 40% risk of transformation to MDS (P < .0002).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP914125.RAYYpjvbNASoBOJzT9Hb-J26KCPG7ZPv--NFg6qOAH5dg130_provenance.
- NP873259.RAb95q_VOko6eWoCVPAdskdKwGQeGa0p2PTYYmVWBd7-8130_assertion description "[Somatic mutations in AA patients with a disease duration of >6 months were associated with a 40% risk of transformation to MDS (P < .0002).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP873259.RAb95q_VOko6eWoCVPAdskdKwGQeGa0p2PTYYmVWBd7-8130_provenance.
- NP781516.RADbcCtJYpThF-4LK80EQN9F6IWcH6md1OC1S1DHmvAcU130_assertion description "[Somatic mutations in AA patients with a disease duration of >6 months were associated with a 40% risk of transformation to MDS (P < .0002).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP781516.RADbcCtJYpThF-4LK80EQN9F6IWcH6md1OC1S1DHmvAcU130_provenance.
- NP1212137.RAYW9As5t1vYct46Dy5zOQuGOjnUPcmUBfAdUh_rgHnU4130_assertion description "[Somatic mutations in AA patients with a disease duration of >6 months were associated with a 40% risk of transformation to MDS (P < .0002).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1212137.RAYW9As5t1vYct46Dy5zOQuGOjnUPcmUBfAdUh_rgHnU4130_provenance.
- NP1212139.RAQPUPFPRwsuPVJICLiPBVZbFBMkd493V3G9LVfkqjjRc130_assertion description "[Somatic mutations in AA patients with a disease duration of >6 months were associated with a 40% risk of transformation to MDS (P < .0002).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1212139.RAQPUPFPRwsuPVJICLiPBVZbFBMkd493V3G9LVfkqjjRc130_provenance.
- NP1212136.RAuA9nLmJAmt8uA3oaGIwI2Tnrx0lH31ArJvFytav83Pw130_assertion description "[Somatic mutations in AA patients with a disease duration of >6 months were associated with a 40% risk of transformation to MDS (P < .0002).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1212136.RAuA9nLmJAmt8uA3oaGIwI2Tnrx0lH31ArJvFytav83Pw130_provenance.
- NP606087.RAxhS_sYVXONvNBE1FhsAE_Fhk2-ocKjmMFVcqxCkq2g8130_assertion description "[Somatic mutations in AA patients with a disease duration of >6 months were associated with a 40% risk of transformation to MDS (P < .0002).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP606087.RAxhS_sYVXONvNBE1FhsAE_Fhk2-ocKjmMFVcqxCkq2g8130_provenance.
- NP978606.RAHb2JEtg4nwpusu9gj0v4OStJ7cLgTX5PxDKRhFQVckQ130_assertion description "[Somatic mutations in AA patients with a disease duration of >6 months were associated with a 40% risk of transformation to MDS (P < .0002).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP978606.RAHb2JEtg4nwpusu9gj0v4OStJ7cLgTX5PxDKRhFQVckQ130_provenance.
- NP1212135.RA-1xG2hmmRFgQGpl6-Cfyu6OxgkEyzfbhbJBBrgGCwNA130_assertion description "[Somatic mutations in AA patients with a disease duration of >6 months were associated with a 40% risk of transformation to MDS (P < .0002).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1212135.RA-1xG2hmmRFgQGpl6-Cfyu6OxgkEyzfbhbJBBrgGCwNA130_provenance.
- NP1212138.RAxtoNYiBysOffzFfrUrospWXlnxcr5Zn2S59Wj0fouW4130_assertion description "[Somatic mutations in AA patients with a disease duration of >6 months were associated with a 40% risk of transformation to MDS (P < .0002).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1212138.RAxtoNYiBysOffzFfrUrospWXlnxcr5Zn2S59Wj0fouW4130_provenance.